162 related articles for article (PubMed ID: 7543196)
1. UV activation of receptor tyrosine kinase activity.
Coffer PJ; Burgering BM; Peppelenbosch MP; Bos JL; Kruijer W
Oncogene; 1995 Aug; 11(3):561-9. PubMed ID: 7543196
[TBL] [Abstract][Full Text] [Related]
2. Roles of insulin receptor substrate-1 and Shc on insulin-like growth factor I receptor signaling in early passages of cultured human fibroblasts.
Takahashi Y; Tobe K; Kadowaki H; Katsumata D; Fukushima Y; Yazaki Y; Akanuma Y; Kadowaki T
Endocrinology; 1997 Feb; 138(2):741-50. PubMed ID: 9003010
[TBL] [Abstract][Full Text] [Related]
3. Different pathways of postreceptor desensitization following chronic insulin treatment and in cells overexpressing constitutively active insulin receptors.
Inoue G; Cheatham B; Kahn CR
J Biol Chem; 1996 Nov; 271(45):28206-11. PubMed ID: 8910437
[TBL] [Abstract][Full Text] [Related]
4. Thyrotropin-releasing hormone stimulates MAP kinase activity in GH3 cells by divergent pathways. Evidence of a role for early tyrosine phosphorylation.
Ohmichi M; Sawada T; Kanda Y; Koike K; Hirota K; Miyake A; Saltiel AR
J Biol Chem; 1994 Feb; 269(5):3783-8. PubMed ID: 7508919
[TBL] [Abstract][Full Text] [Related]
5. The protein product of the c-cbl oncogene rapidly complexes with the EGF receptor and is tyrosine phosphorylated following EGF stimulation.
Bowtell DD; Langdon WY
Oncogene; 1995 Oct; 11(8):1561-7. PubMed ID: 7478580
[TBL] [Abstract][Full Text] [Related]
6. The effect of cyclic adenosine monophosphate on the mitogen-activated protein kinase pathway depends on both the cell type and the type of tyrosine kinase-receptor.
Calleja V; Ruiz Enríquez P; Filloux C; Peraldi P; Baron V; Van Obberghen E
Endocrinology; 1997 Mar; 138(3):1111-20. PubMed ID: 9048617
[TBL] [Abstract][Full Text] [Related]
7. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.
Guvakova MA; Surmacz E
Cancer Res; 1997 Jul; 57(13):2606-10. PubMed ID: 9205064
[TBL] [Abstract][Full Text] [Related]
8. Fatty acid induced insulin resistance in rat-1 fibroblasts overexpressing human insulin receptors: impaired insulin-stimulated mitogen-activated protein kinase activity.
Usui I; Takata Y; Imamura T; Morioka H; Sasaoka T; Sawa T; Ishihara H; Ishiki M; Kobayashi M
Diabetologia; 1997 Aug; 40(8):894-901. PubMed ID: 9267983
[TBL] [Abstract][Full Text] [Related]
9. Differential coupling of membrane Ig and CD40 to the extracellularly regulated kinase signaling pathway.
Purkerson JM; Parker DC
J Immunol; 1998 Mar; 160(5):2121-9. PubMed ID: 9498749
[TBL] [Abstract][Full Text] [Related]
10. Functional importance of Shc tyrosine 317 on insulin signaling in Rat1 fibroblasts expressing insulin receptors.
Ishihara H; Sasaoka T; Ishiki M; Takata Y; Imamura T; Usui I; Langlois WJ; Sawa T; Kobayashi M
J Biol Chem; 1997 Apr; 272(14):9581-6. PubMed ID: 9083103
[TBL] [Abstract][Full Text] [Related]
11. The uncoupling of Shc activation from distal intracellular signalling in a cell line which expresses a truncated human epidermal growth factor receptor.
McNeil A; Larkins R; Clark S
Biochem Biophys Res Commun; 1996 Jan; 218(3):740-4. PubMed ID: 8579583
[TBL] [Abstract][Full Text] [Related]
12. Taxol induces tyrosine phosphorylation of Shc and its association with Grb2 in murine RAW 264.7 cells.
Wolfson M; Yang CP; Horwitz SB
Int J Cancer; 1997 Jan; 70(2):248-52. PubMed ID: 9009167
[TBL] [Abstract][Full Text] [Related]
13. The coupling of alpha6beta4 integrin to Ras-MAP kinase pathways mediated by Shc controls keratinocyte proliferation.
Mainiero F; Murgia C; Wary KK; Curatola AM; Pepe A; Blumemberg M; Westwick JK; Der CJ; Giancotti FG
EMBO J; 1997 May; 16(9):2365-75. PubMed ID: 9171350
[TBL] [Abstract][Full Text] [Related]
14. Cellular effects of phosphotyrosine-binding domain inhibitors on insulin receptor signaling and trafficking.
Giorgetti-Peraldi S; Ottinger E; Wolf G; Ye B; Burke TR; Shoelson SE
Mol Cell Biol; 1997 Mar; 17(3):1180-8. PubMed ID: 9032245
[TBL] [Abstract][Full Text] [Related]
15. Opposite effects of the p52shc/p46shc and p66shc splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway.
Migliaccio E; Mele S; Salcini AE; Pelicci G; Lai KM; Superti-Furga G; Pawson T; Di Fiore PP; Lanfrancone L; Pelicci PG
EMBO J; 1997 Feb; 16(4):706-16. PubMed ID: 9049300
[TBL] [Abstract][Full Text] [Related]
16. Activation loop tyrosines contribute varying roles to TrkB autophosphorylation and signal transduction.
McCarty JH; Feinstein SC
Oncogene; 1998 Apr; 16(13):1691-700. PubMed ID: 9582017
[TBL] [Abstract][Full Text] [Related]
17. Activation of the Ras/mitogen-activated protein kinase pathway by kinase-defective epidermal growth factor receptors results in cell survival but not proliferation.
Walker F; Kato A; Gonez LJ; Hibbs ML; Pouliot N; Levitzki A; Burgess AW
Mol Cell Biol; 1998 Dec; 18(12):7192-204. PubMed ID: 9819406
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone stimulates tyrosine phosphorylation of JAK2 and STAT5, but not insulin receptor substrate-1 or SHC proteins in liver and skeletal muscle of normal rats in vivo.
Chow JC; Ling PR; Qu Z; Laviola L; Ciccarone A; Bistrian BR; Smith RJ
Endocrinology; 1996 Jul; 137(7):2880-6. PubMed ID: 8770909
[TBL] [Abstract][Full Text] [Related]
19. Modulation of insulin-like growth factor I mitogenic signaling in 3T3-L1 preadipocyte differentiation.
Boney CM; Smith RM; Gruppuso PA
Endocrinology; 1998 Apr; 139(4):1638-44. PubMed ID: 9528944
[TBL] [Abstract][Full Text] [Related]
20. Crk protein binds to PDGF receptor and insulin receptor substrate-1 with different modulating effects on PDGF- and insulin-dependent signaling pathways.
Sorokin A; Reed E; Nnkemere N; Dulin NO; Schlessinger J
Oncogene; 1998 May; 16(19):2425-34. PubMed ID: 9627109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
